Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Shares Outstanding (Weighted Average) (2016 - 2021)

Historic Shares Outstanding (Weighted Average) for Neurocrine Biosciences (NBIX) over the last 12 years, with Q3 2021 value amounting to $94.7 million.

  • Neurocrine Biosciences' Shares Outstanding (Weighted Average) rose 150.05% to $94.7 million in Q3 2021 from the same period last year, while for Sep 2021 it was $94.7 million, marking a year-over-year increase of 150.05%. This contributed to the annual value of $93.5 million for FY2020, which is 141.0% up from last year.
  • As of Q3 2021, Neurocrine Biosciences' Shares Outstanding (Weighted Average) stood at $94.7 million, which was up 150.05% from $94.6 million recorded in Q2 2021.
  • Neurocrine Biosciences' 5-year Shares Outstanding (Weighted Average) high stood at $94.7 million for Q3 2021, and its period low was $88063.0 during Q2 2017.
  • Moreover, its 5-year median value for Shares Outstanding (Weighted Average) was $91.6 million (2019), whereas its average is $81.5 million.
  • Per our database at Business Quant, Neurocrine Biosciences' Shares Outstanding (Weighted Average) plummeted by 9989.84% in 2017 and then surged by 10134284.13% in 2019.
  • Neurocrine Biosciences' Shares Outstanding (Weighted Average) (Quarter) stood at $88.7 million in 2017, then rose by 1.73% to $90.2 million in 2018, then increased by 2.22% to $92.2 million in 2019, then grew by 1.41% to $93.5 million in 2020, then rose by 1.28% to $94.7 million in 2021.
  • Its Shares Outstanding (Weighted Average) was $94.7 million in Q3 2021, compared to $94.6 million in Q2 2021 and $94.2 million in Q1 2021.